In this study, we show that a self-inactivating (SIN) alpharetroviral vector system can be successfully used to deliver and stably express a CAR designed to recognize the AML target antigen CD123, hIL-15, and EGFP. Here, IL3RA is linked to acute myeloid leukemia.